|
Volumn , Issue , 2013, Pages
|
Novel approaches to treatment of double-refractory multiple myeloma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
TUMOR MARKER;
ANIMAL;
DRUG DESIGN;
DRUG EFFECTS;
DRUG RESISTANCE;
GENETICS;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
MULTIPLE MYELOMA;
PATHOLOGY;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG DESIGN;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MOLECULAR TARGETED THERAPY;
MULTIPLE MYELOMA;
SIGNAL TRANSDUCTION;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 84946220659
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e302 Document Type: Review |
Times cited : (18)
|
References (0)
|